ABVC BioPharma Inc. Revenue 2010–2025
ABVC BioPharma Inc. annual/quarterly revenue history and growth rate from 2010 to 2025. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- ABVC BioPharma Inc. revenue for the quarter ending September 30, 2025 was 795950, a 104.47% increase year-over-year.
- ABVC BioPharma Inc. revenue for the twelve months ending September 30, 2025 was 1.3 M, a 577.06% increase year-over-year.
- ABVC BioPharma Inc. annual revenue for 2025 was 296000, a 41.91% decrease from 2024.
- ABVC BioPharma Inc. annual revenue for 2024 was 509589, a 234.31% increase from 2023.
- ABVC BioPharma Inc. annual revenue for 2023 was 152430, a 84.28% decrease from 2022.
- ABVC BioPharma Inc. annual revenue for 2022 was 969783.
ABVC BioPharma Inc. (ABVC) — Frequently Asked Questions
ABVC BioPharma Inc. (ABVC) is a publicly traded US company. It has a market capitalization of $26M. In fiscal 2025 it reported revenue of $296,000 and net income of -$8M. Explore ABVC's stock price, financial statements, earnings history, margins and key ratios below.
What is ABVC BioPharma Inc.'s market cap?
ABVC BioPharma Inc. (ABVC) has a market capitalization of $26M.
What is the ABVC stock price?
ABVC trades at $1.29 (-2.27% on the day).
How much revenue does ABVC BioPharma Inc. make?
ABVC BioPharma Inc. reported revenue of $296,000 in fiscal 2025.
Is ABVC profitable?
In fiscal 2025, ABVC BioPharma Inc. reported net income of -$8M.